Whole genome methylation sequencing reveals epigenetic landscape and abnormal expression of FABP5 in extramammary Paget's disease
Open Access
- 16 October 2023
- journal article
- research article
- Published by Wiley in Skin Research and Technology
- Vol. 29 (10) , e13497
Abstract
Background: Extramammary Paget's disease (EMPD) is a rare cutaneous malignant tumor with a high recurrence rate after surgery. However, the genetic and epigenetic alterations underlying its pathogenesis remain unknown. DNA methylation is an important epigenetic modification involved in many biological processes. Methods: In this study, enzymatic methyl‐sequencing (EM‐seq) technique was used to investigate the landscape of genome‐wide DNA methylation from three pairs of tumor tissues and adjacent tissues of patients with EMPD. Additionally, we conducted histopathological examinations to assess the expression of fatty acid‐binding protein 5 (FABP5) in another three paired samples from EMPD patients. Results: The cluster analysis showed the good quality of the samples. A differential methylation region (DMR) heat map was used to quantitatively characterize genome‐wide methylation differences between tumors and controls. Global DNA methylation level is lower in EMPD tissue compared to matched controls, indicating that DNA methylation discriminates between tumor and normal skin. And the top hypomethylation gene on the promoter region in tumor tissues was FABP5 on chromosome 8 with 38.44% decreased median methylation. We next identified the expression of FABP5 in paired tumors and adjacent tissues in three additional patients with EMPD. Immunofluorescence results showed FABP5 highly expressed in tumor tissues and co‐located with CK7, CK20 and EMA. GO and KEGG enrichment analysis showed DMR genes on promoter are mainly enriched in the calcium ion transport, GTPase mediated signal transduction, Rap1 signaling pathway and GnRH signaling pathway. Conclusion: Taken together, our findings provide the first description of the whole genome methylation map of EMPD and identify FABP5 as a pathogenic target of EMPD.Keywords
Funding Information
- National Natural Science Foundation of China (82073013)
- Natural Science Foundation of Shanghai Municipality (21ZR1457100)
This publication has 47 references indexed in Scilit:
- Fatty Acid-Binding Protein E-FABP Restricts Tumor Growth by Promoting IFN-β Responses in Tumor-Associated MacrophagesCancer Research, 2014
- Extramammary Paget’s Disease: 20 Years of Experience in Chinese PopulationInternational Journal of Surgical Oncology, 2012
- Global DNA hypomethylation in cancer: review of validated methods and clinical significanceClinical Chemistry and Laboratory Medicine (CCLM), 2012
- The Role of Immunohistochemistry in Discriminating Primary From Secondary Extramammary Paget DiseaseThe American Journal of Dermatopathology, 2010
- Will GnRH antagonists improve prostate cancer treatment?Trends in Endocrinology & Metabolism, 2009
- Fatty acid-binding proteins: role in metabolic diseases and potential as drug targetsNature Reviews Drug Discovery, 2008
- Cancer epigenomics: DNA methylomes and histone-modification mapsNature Reviews Genetics, 2007
- Mammary and extramammary Paget's disease: an immunohistochemical study of 83 casesHistopathology, 2007
- The MAPK signalling pathways and colorectal cancerThe Lancet Oncology, 2005
- Paget’s disease of the breastCancer Treatment Reviews, 2001